Purple Other Current Liab from 2010 to 2025

PPBT Stock  USD 2.69  0.05  1.82%   
Purple Biotech Other Current Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Current Liabilities will likely drop to about 2.2 M in 2025. From the period from 2010 to 2025, Purple Biotech Other Current Liabilities quarterly data regression had r-value of  0.67 and coefficient of variation of  60.15. View All Fundamentals
 
Other Current Liabilities  
First Reported
2014-12-31
Previous Quarter
3.4 M
Current Value
2.3 M
Quarterly Volatility
5.7 M
 
Yuan Drop
 
Covid
Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 195.3 K, Interest Expense of 39 K or Selling General Administrative of 4.5 M, as well as many indicators such as Price To Sales Ratio of 11.28, Dividend Yield of 0.088 or PTB Ratio of 0.0203. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.
  
Check out the analysis of Purple Biotech Correlation against competitors.
For more information on how to buy Purple Stock please use our How to Invest in Purple Biotech guide.

Latest Purple Biotech's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Purple Biotech over the last few years. It is Purple Biotech's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Purple Biotech's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Purple Other Current Liab Regression Statistics

Arithmetic Mean1,854,397
Geometric Mean1,575,472
Coefficient Of Variation60.15
Mean Deviation868,822
Median1,693,000
Standard Deviation1,115,415
Sample Variance1.2T
Range4.2M
R-Value0.67
Mean Square Error732.4B
R-Squared0.45
Significance0
Slope157,267
Total Sum of Squares18.7T

Purple Other Current Liab History

20252.2 M
20242.3 M
20233.5 M
20224.7 M
20212.6 M
20201.7 M
20191.1 M

About Purple Biotech Financial Statements

Purple Biotech shareholders use historical fundamental indicators, such as Other Current Liab, to determine how well the company is positioned to perform in the future. Although Purple Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Purple Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Purple Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Liabilities2.3 M2.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Purple Stock Analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.